Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials

Severine Loisel-Meyer1, Ronan Foley, Jeffrey A Medin

  • 1Ontario Cancer Institute, University Health Network, 67 College Street, Toronto (ON) Canada M5G 2M1.

Insights

Cancer immunotherapy is evolving, focusing on stimulating the immune system or targeting tumor antigens. Recent strategies combine targeting tumor antigens with immune stimulation, showing promise for advanced cancers.

Area of Science:

  • Oncology
  • Immunology
  • Gene Therapy

Background:

  • Cancer immunotherapy aims to stimulate the immune system or engineer responses against tumor-associated antigens (TAA).
  • Recent advancements focus on translating immuno-gene therapy strategies into clinical applications for diverse cancers.

Purpose of the Study:

  • To review the evolution of anti-cancer immunotherapy strategies.
  • To highlight recent developments in immuno-gene therapy clinical trials.

Main Methods:

  • Review of recent literature on immuno-gene therapy strategies.
  • Focus on clinical trial translations and evolving therapeutic approaches.

Main Results:

  • Shift from solely expressing immuno-stimulatory molecules or TAA to combined strategies.
  • Integration of direct/viral cytokine or co-stimulatory molecule administration.
  • Encouraging results from combining genetic immunotherapy with chemotherapy.

Conclusions:

  • Current immuno-gene therapy strategies are evolving towards dual targeting and immune stimulation.
  • Combination therapies, including genetic immunotherapy with chemotherapy, show potential for advanced cancers.
  • These novel approaches may offer new treatment perspectives for patients with advanced-stage cancer.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...